Arkansas Children's Hospital Research Institute
archildrens.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
122
Active
37
Phase 3
0
Total enrollment
19,013
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketorolac | — | — | — | — | — | 1 | |
| Elexacaftor / Ivacaftor / Tezacaftor | — | — | — | — | — | 1 | |
| Ruxolitinib | — | — | — | — | — | 1 |
Next readouts
- 2025-05
- 2028-11-19
- 2030-12
Top conditions
- Healthy32
- Asthma11
- Insulin Resistance5
- Obesity4
- Eosinophilic Esophagitis3
- Pregnancy3
- Premature Birth2
- Physical Activities2
Frequently asked questions about Arkansas Children's Hospital Research Institute
- How many clinical trials does Arkansas Children's Hospital Research Institute have on ClinicalTrials.gov?
- Arkansas Children's Hospital Research Institute is listed as the lead sponsor on 122 clinical trials in ClinicalTrials.gov, 37 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Arkansas Children's Hospital Research Institute's trials are in Phase 3?
- 0 of Arkansas Children's Hospital Research Institute's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Arkansas Children's Hospital Research Institute focus on?
- Arkansas Children's Hospital Research Institute's most-studied conditions on ClinicalTrials.gov are Healthy, Asthma, Insulin Resistance, Obesity, Eosinophilic Esophagitis.
- When are Arkansas Children's Hospital Research Institute's next clinical trial readouts?
- Arkansas Children's Hospital Research Institute has 3 upcoming primary-completion readouts tracked here; the soonest is “Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement”, expected around 2025-05.